The former U.S. Food and Drug Administration chief shut out two senior agency officials from a decision to indefinitely postpone action on Barr Pharmaceuticals Inc.’s “morning-after” contraceptive, the officials said in legal depositions.
The former U.S. Food and Drug Administration chief shut out two senior agency officials from a decision to indefinitely postpone action on Barr Pharmaceuticals Inc.’s “morning-after” contraceptive, the officials said in legal depositions.